Author:
Poleszak Ewa,Stasiuk Weronika,Szopa Aleksandra,Wyska Elżbieta,Serefko Anna,Oniszczuk Anna,Wośko Sylwia,Świąder Katarzyna,Wlaź Piotr
Funder
Funds for Statutory Activity of Medical University of Lublin
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Biochemistry
Reference81 articles.
1. Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA (2008) Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32:1879–1883
2. Brimecombe JC, Gallagher MJ, Lynch DR, Aizenman E (1998) An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-d-aspartate receptors. J Pharmacol Exp Ther 286:627–634
3. Chazot PL, Lawrence S, Thompson CL (2002) Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists. Neuropharmacology 42:319–324
4. Chenard BL, Bordner J, Butler TW, Chambers LK, Collins MA, De Costa DL, Ducat MF, Dumont ML, Fox CB, Mena EE, Menniti FS, Nielsen J, Pagnozzi MJ, Richter KEG, Ronau RT, Shalaby IA, Stemple JZ, White WF (1995) (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J Med Chem 38:3138–3145
5. Cichy A, Sowa-Kućma M, Legutko B, Pomierny-Chamioło L, Siwek A, Piotrowska A, Szewczyk B, Poleszak E, Pilc A, Nowak G (2009) Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep 61:1184–1191
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献